Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAhZAqxG-GpkcDR0aMDd2ymItam2JxwJETPbOjZFlPvvg#assertion>. }
Showing items 1 to 9 of
9
with 100 items per page.
- association type Statement assertion.
- association label ""FOSAMAX is contraindicated in patients with the following conditions: Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia [see Warnings and Precautions (5.1) Inability to stand or sit upright for at least 30 minutes [see Dosage and Administration (2.6) Warnings and Precautions (5.1) Do not administer FOSAMAX oral solution to patients at increased risk of aspiration. Hypocalcemia [see Warnings and Precautions (5.2) Hypersensitivity to any component of this product. Hypersensitivity reactions including urticaria and angioedema have been reported [see Adverse Reactions (6.2) Abnormalities of the esophagus which delay emptying such as stricture or achalasia ( 4 5.1 Inability to stand/sit upright for at least 30 minutes ( 2.6 4 5.1 Do not administer FOSAMAX oral solution to patients at increased risk of aspiration. ( 4 Hypocalcemia ( 4 5.2 Hypersensitivity to any component of this product ( 4 6.2"" assertion.
- association object DOID_9164 assertion.
- association predicate treats assertion.
- association subject drugbank:DB00630 assertion.
- association relation MedicalContraindication assertion.
- drugbank:DB00630 category Drug assertion.
- DOID_9164 category Disease assertion.
- association provided_by NeuroDKG assertion.